NBA: Celtics C Kristaps Porzingis (plantar fasciitis) out 4-6 weeks

Date:

Share post:


Boston Celtics center Kristaps Porzingis will spend the next four to six weeks rehabbing his right foot after being diagnosed with plantar fasciitis, the team announced Wednesday.

The veteran big man, acquired in a three-team trade from the Washington Wizards in June, is expected to be ready for the start of training camp.

The foot injury forced Porzingis to announce Tuesday that he won’t compete for Latvia at the upcoming FIBA Basketball World Cup.

Porzingis, 28, averaged a career-best 23.2 points for the Wizards last season as well as 8.4 rebounds, 2.7 assists and 1.5 blocks in 65 games. He also shot a career-best 49.8 percent from the floor, with his 38.5 percent accuracy on 3-pointers the second best of his career.

A 2017-18 All-Star, Porzingis has averaged 19.6 points and 7.9 rebounds in seven seasons with the New York Knicks (2015-18), Dallas Mavericks (2019-22) and Wizards (2022-23).

Porzingis exercised the $36 million option on his contract for the upcoming season to facilitate the trade that saw guard Marcus Smart dealt to the Memphis Grizzlies.

Boston later signed Porzingis to a two-year extension that runs through the 2025-26 season.

–Field Level Media

spot_img

Related articles

WNBA: Allisha Gray’s hot shooting powers Dream past Mystics

Allisha Gray's career-high 32 points and 6-of-9 shooting from 3-point range powered a flurry of long-range offense as...

WNBA: Angel Reese’s triple-double carries Sky past Sun

Angel Reese delivered her first WNBA triple-double with 11 points, 13 rebounds and 11 assists to lead the...

WNBA: Kayla Thornton paces Valkyries past Storm

Kayla Thornton highlighted a 22-point performance with a rally-stopping 3-pointer midway through the fourth quarter and the Golden...

WNBA: Caitlin Clark dominates in return, Fever topple Liberty

Caitlin Clark totaled 32 points, nine assists and eight rebounds in a spectacular return from a left quad...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.